Pediatric quetiapine overdose: a case report and literature review.

Quetiapine is a medication approved for the treatment of psychotic disorders in adults. At this time it is not approved for the treatment of children or adolescents. It is an atypical antipsychotic agent that is efficacious in treating both the positive and negative symptoms of schizophrenia. There is currently little information available concerning the safety of quetiapine in overdose, and there are no previous case reports of quetiapine overdose in the pediatric population. We present the case of a 15-year-old girl who ingested 1250 mg of quetiapine (21.6 mg/kg) in a suicide attempt. She developed multiple symptoms including tachycardia, agitation, hypotension, and unconsciousness. We compare her symptoms to previous adult cases of quetiapine overdose and review overdose treatment recommendations. We also examine clinical situations that may lead to a more severe clinical course.

[1]  J. Lewis,et al.  A study of quetiapine: efficacy and tolerability in psychotic adolescents. , 2001, Journal of child and adolescent psychopharmacology.

[2]  H. Parraga,et al.  Quetiapine for Tourette's syndrome. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  M. J. Burns.  The Pharmacology and Toxicology of Atypical Antipsychotic Agents , 2001, Journal of toxicology. Clinical toxicology.

[4]  J. Raniwalla,et al.  Quetiapine: a review of its safety in the management of schizophrenia. , 2000, Drug safety.

[5]  C. Lore.  Risperidone and withdrawal dyskinesia. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  K. Zbuk,et al.  Quetiapine fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions , 2000, Clinical pharmacology and therapeutics.

[7]  S. Kasper,et al.  Review of quetiapine and its clinical applications in schizophrenia , 2000, Expert opinion on pharmacotherapy.

[8]  L. Wilkinson,et al.  Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. , 2000, The Journal of clinical psychiatry.

[9]  P. Gajwani,et al.  Olanzapine-induced neutropenia. , 2000, Psychosomatics.

[10]  P. Gajwani,et al.  QT interval prolongation associated with quetiapine (Seroquel) overdose. , 2000, Psychosomatics.

[11]  F. Hustey.  Acute quetiapine poisoning. , 1999, The Journal of emergency medicine.

[12]  R. Pipe,et al.  Quetiapine in adolescent psychosis. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  D. Behar,et al.  Quetiapine for refractory mania in a child. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  B. Green.  Focus on quetiapine. , 1999, Current medical research and opinion.

[15]  J. Bregman,et al.  Open-label quetiapine in the treatment of children and adolescents with autistic disorder. , 1999, Journal of child and adolescent psychopharmacology.

[16]  R. Findling,et al.  Quetiapine for refractory schizophrenia. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  L. Viñuela,et al.  Safety in overdose of quetiapine: a case report. , 1998, The Journal of clinical psychiatry.

[18]  D. Greenblatt,et al.  Drug interactions with newer antidepressants: role of human cytochromes P450. , 1998, The Journal of clinical psychiatry.

[19]  E. Krenzelok,et al.  Loss of consciousness from acute quetiapine overdosage. , 1998, Journal of toxicology. Clinical toxicology.

[20]  S. Schulz,et al.  Antipsychotic medications in children and adolescents. , 2001, The Journal of clinical psychiatry.

[21]  Harold I. Kaplan,et al.  Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry , 1994 .